Stefano Petruzzelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stefano Petruzzelli has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
C Giuntini
9 shared publicationsA Palla
5 shared publicationsV Donnamaria
4 shared publicationsA M Camus
2 shared publicationsG Rossi
2 shared publicationsH Bartsch
2 shared publications
Latest Publications
- 1 November 2000
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 2 (4) , 345-350
Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program
Twenty healthy, asymptomatic long-term cigarette smokers (8 males, 12 females; mean age: 43 ±9 years) were selected at random from a larger series receiving nicotine replacement therapy (NRT) for 12 weeks to study the effects of NRT on plasma markers of oxidative stress. Plasma aliquots, obtained at baseline (T0) and after 12 weeks (T12) of NRT, were used to measure malondialdeyde (MDA) and total Trolox-equivalent antioxidant capacity (TEAC). In subjects who completely quit smoking (‘quitters’, n = 10), MDA was higher at T0 (1.08 μmol/l, interquartile range 0.85–1.16) than at T12 (0.71 μmol/l, range 0.32–0.92; p <0.01), and TEAC was lower at T0 (1.20 mM, range 1.11–1.31) than at T12 (1.43 mM, range 1.31–1.49; p <0.05). In subjects who had only reduced the number of cigarettes smoked per day (‘reducers’, n = 10), differences between the T0 and T12 levels of MDA (0.81 [0.75–0.96] vs. 0.76 [0.58–0.84] μmol/l) and TEAC (1.28 [1.05–1.50] vs. 1.25 [1.09–1.42] mM) were not significant. At T0, MDA and cotinine levels correlated in reducers (r = 0.79, p <0.05) and, though not significantly, in quitters (r = 0.50, p = 0.12). At T12 this relationship between MDA and cotinine was still present in the reducers (r = 0.70, p <0.05), while the scatter of points in quitters was completely dispersed (r = (0.09). These results show that smoking cessation but not smoking reduction is associated with decreased markers of oxidative stress in the plasma of active cigarette smokers.
- 1 November 2000
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 2 (4) , 345-350
Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program
Twenty healthy, asymptomatic long-term cigarette smokers (8 males, 12 females; mean age: 43 ±9 years) were selected at random from a larger series receiving nicotine replacement therapy (NRT) for 12 weeks to study the effects of NRT on plasma markers of oxidative stress. Plasma aliquots, obtained at baseline (T0) and after 12 weeks (T12) of NRT, were used to measure malondialdeyde (MDA) and total Trolox-equivalent antioxidant capacity (TEAC). In subjects who completely quit smoking (‘quitters’, n = 10), MDA was higher at T0 (1.08 μmol/l, interquartile range 0.85–1.16) than at T12 (0.71 μmol/l, range 0.32–0.92; p <0.01), and TEAC was lower at T0 (1.20 mM, range 1.11–1.31) than at T12 (1.43 mM, range 1.31–1.49; p <0.05). In subjects who had only reduced the number of cigarettes smoked per day (‘reducers’, n = 10), differences between the T0 and T12 levels of MDA (0.81 [0.75–0.96] vs. 0.76 [0.58–0.84] μmol/l) and TEAC (1.28 [1.05–1.50] vs. 1.25 [1.09–1.42] mM) were not significant. At T0, MDA and cotinine levels correlated in reducers (r = 0.79, p <0.05) and, though not significantly, in quitters (r = 0.50, p = 0.12). At T12 this relationship between MDA and cotinine was still present in the reducers (r = 0.70, p <0.05), while the scatter of points in quitters was completely dispersed (r = (0.09). These results show that smoking cessation but not smoking reduction is associated with decreased markers of oxidative stress in the plasma of active cigarette smokers.
- 1 June 1994
- Vol. 49 (3) , 235-8
Host factors in lung carcinogenesis.
The interaction between aetiological factors (e.g. tobacco smoke) and target cells in lung tissues is modulated by host factors, leading to variable risk among individuals. We have studied some of the metabolic properties of the human lung and the effects on them of tobacco smoke. The activity of activating enzymes is induced by recent tobacco smoke exposure, whereas that of inactivating enzymes is depressed, and this effect is greater in patients with lung cancer than in controls. This imbalance between activating and detoxifying enzymes in the lung may be a key factor in determining the genetic damage to the lung. These differences between lung cancer patients and controls in metabolic activities in lung tissues may be documented at a phenotypic level as well as at a genotypic level. Also wide interindividual differences have been shown in deoxyribonucleic acid (DNA) repair enzymes and in the extent of DNA damage.
- 1 June 1994
- Vol. 49 (3) , 235-8
Host factors in lung carcinogenesis.
The interaction between aetiological factors (e.g. tobacco smoke) and target cells in lung tissues is modulated by host factors, leading to variable risk among individuals. We have studied some of the metabolic properties of the human lung and the effects on them of tobacco smoke. The activity of activating enzymes is induced by recent tobacco smoke exposure, whereas that of inactivating enzymes is depressed, and this effect is greater in patients with lung cancer than in controls. This imbalance between activating and detoxifying enzymes in the lung may be a key factor in determining the genetic damage to the lung. These differences between lung cancer patients and controls in metabolic activities in lung tissues may be documented at a phenotypic level as well as at a genotypic level. Also wide interindividual differences have been shown in deoxyribonucleic acid (DNA) repair enzymes and in the extent of DNA damage.
- 15 November 1992
- Vol. 52 (22) , 6248-53
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
An improved high-performance liquid chromatography/fluorometric assay has been established to quantitate the benzo(a)pyrene (BP) tetrols released after acid hydrolysis of lung DNA from lung cancer patients, so that the formation of benzo(a)pyrene diol-epoxide-DNA adducts can be measured. The r-7,c-10,t-8,t-9-tetrahydroxy-7,8,9,10-tetrahydro-BP isolated by high-performance liquid chromatography was determined by chromatography in two different solvent systems and fluorescence spectroscopy. This assay has a detection limit of 2 pg of r-7,c-10,t-8,t-9-tetrahydroxy- 7,8,9,10-tetrahydro-BP, requires 100-500 micrograms of DNA, and can measure 1 adduct/10(8) unmodified nucleotides. As this assay does not use immunoaffinity chromatography or solvent extraction, it allows a > 90% recovery of benzo(a)pyrene diol-epoxide-DNA adducts. This procedure has been tested on 13 DNA samples prepared from nontumorous lung parenchyma taken from lung cancer patients at surgery and revealed the presence of DNA adducts of the anti-benzo(a)pyrene diol-epoxide in 9 of 11 samples from smokers and in 2 of 2 ex-smokers. In only two samples from smokers the formation of adducts derived from syn-benzo(a)pyrene diol-epoxide was detected. A 15-fold variation in DNA adduct level was found in 11 of 13 DNA samples, with a range of 0.6-9.9 adducts of benzo(a)pyrene diol-epoxide/10(8) nucleotides. In samples containing both anti- and syn-benzo(a)pyrene diolepoxide-DNA adducts, the anti/syn adduct ratio is 2:1. A highly significant correlation was found between pulmonary microsomal aryl hydrocarbon hydroxylase activity and the level of benzo(a)pyrene diolepoxide-DNA adduct (r = 0.91; P < 0.001; n = 13). A crude linear correlation between the amounts of these adducts and those of bulky DNA adducts determined by 32P-postlabeling assay was observed in the same samples (r = 0.78; P < 0.02; n = 13). Thus this highly sensitive and specific procedure is suitable for measuring benzo(a)pyrene diolepoxide-DNA adducts in human tissues from environmentally exposed subjects and could be adapted to measure polycyclic aromatic hydrocarbons other than BP.
- 15 November 1992
- Vol. 52 (22) , 6248-53
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
An improved high-performance liquid chromatography/fluorometric assay has been established to quantitate the benzo(a)pyrene (BP) tetrols released after acid hydrolysis of lung DNA from lung cancer patients, so that the formation of benzo(a)pyrene diol-epoxide-DNA adducts can be measured. The r-7,c-10,t-8,t-9-tetrahydroxy-7,8,9,10-tetrahydro-BP isolated by high-performance liquid chromatography was determined by chromatography in two different solvent systems and fluorescence spectroscopy. This assay has a detection limit of 2 pg of r-7,c-10,t-8,t-9-tetrahydroxy- 7,8,9,10-tetrahydro-BP, requires 100-500 micrograms of DNA, and can measure 1 adduct/10(8) unmodified nucleotides. As this assay does not use immunoaffinity chromatography or solvent extraction, it allows a > 90% recovery of benzo(a)pyrene diol-epoxide-DNA adducts. This procedure has been tested on 13 DNA samples prepared from nontumorous lung parenchyma taken from lung cancer patients at surgery and revealed the presence of DNA adducts of the anti-benzo(a)pyrene diol-epoxide in 9 of 11 samples from smokers and in 2 of 2 ex-smokers. In only two samples from smokers the formation of adducts derived from syn-benzo(a)pyrene diol-epoxide was detected. A 15-fold variation in DNA adduct level was found in 11 of 13 DNA samples, with a range of 0.6-9.9 adducts of benzo(a)pyrene diol-epoxide/10(8) nucleotides. In samples containing both anti- and syn-benzo(a)pyrene diolepoxide-DNA adducts, the anti/syn adduct ratio is 2:1. A highly significant correlation was found between pulmonary microsomal aryl hydrocarbon hydroxylase activity and the level of benzo(a)pyrene diolepoxide-DNA adduct (r = 0.91; P < 0.001; n = 13). A crude linear correlation between the amounts of these adducts and those of bulky DNA adducts determined by 32P-postlabeling assay was observed in the same samples (r = 0.78; P < 0.02; n = 13). Thus this highly sensitive and specific procedure is suitable for measuring benzo(a)pyrene diolepoxide-DNA adducts in human tissues from environmentally exposed subjects and could be adapted to measure polycyclic aromatic hydrocarbons other than BP.
- 1 January 1991
- Vol. 35 (1) , 10-3
Reversibility of complete unperfusion in a patient with recurrent hemoptysis.
We present a case of a 68-year-old woman with a history of mild smoking and chronic bronchitis who showed recurrent hemoptysis. She presented with a nearly normal chest roentgenogram, a non-diagnostic fiberoptic bronchoscopy and a computed tomography and lung scanning both of which were highly suggestive for malignancy. In fact, the former showed obstruction of the main left bronchus, of the superior bronchus for the left upper lobe and of the apical bronchus for the left lower lobe, the latter showed a total cessation of blood flow through the left lung. Pulmonary angiography, however, was normal and aortography showed dilatated and twisted left bronchial arteries. Computed tomography and lung scanning came back to normal after bronchoscopic aspiration of endobronchial clots and a nonspecific antibiotic therapy were carried out. Although very infrequent, bronchial stenosis on CT and complete monolateral unperfusion on lung scintigraphy may occur in patients with hemoptysis of benign origin. We recommend the use of pulmonary arteriography in patients with the above pattern when diagnostic doubt remains after bronchoscopy.
- 1 January 1991
- Vol. 35 (1) , 10-3
Reversibility of complete unperfusion in a patient with recurrent hemoptysis.
We present a case of a 68-year-old woman with a history of mild smoking and chronic bronchitis who showed recurrent hemoptysis. She presented with a nearly normal chest roentgenogram, a non-diagnostic fiberoptic bronchoscopy and a computed tomography and lung scanning both of which were highly suggestive for malignancy. In fact, the former showed obstruction of the main left bronchus, of the superior bronchus for the left upper lobe and of the apical bronchus for the left lower lobe, the latter showed a total cessation of blood flow through the left lung. Pulmonary angiography, however, was normal and aortography showed dilatated and twisted left bronchial arteries. Computed tomography and lung scanning came back to normal after bronchoscopic aspiration of endobronchial clots and a nonspecific antibiotic therapy were carried out. Although very infrequent, bronchial stenosis on CT and complete monolateral unperfusion on lung scintigraphy may occur in patients with hemoptysis of benign origin. We recommend the use of pulmonary arteriography in patients with the above pattern when diagnostic doubt remains after bronchoscopy.
- 1 July 1989
- Vol. 44, 679-86
[Pulmonary metabolic activity in relation to carcinogenic substance exposure].
- 1 July 1989
- Vol. 44, 679-86
[Pulmonary metabolic activity in relation to carcinogenic substance exposure].
- 1 October 1988
- Vol. 32 (4) , 248-51
Recovery of pulmonary perfusion in pulmonary embolism complicated with infarction.
- 1 October 1988
- Vol. 32 (4) , 248-51
Recovery of pulmonary perfusion in pulmonary embolism complicated with infarction.
- 1 September 1987
- Vol. 47 (17) , 4740-5
Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits.
The S-12 fractions of lung peripheral parenchyma obtained from 80 male individuals, aged 17-71 years, were assayed as blind samples for the ability either to convert promutagens into bacterial mutagens or to decrease the potency of direct-acting mutagens in the Ames reversion test. In this system, lung preparations were completely ineffective in activating an N-nitroso compound (i.e., N-nitrosomorpholine) and polycyclic aromatic hydrocarbons [i.e., 3-methylcholanthrene and benzo(a)pyrene] or their metabolites [i.e., 3-hydroxy-benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol]. They yielded a borderline and sporadic activation of a cigarette smoke condensate, and a weak but frequent activation of an aromatic amine (i.e., 2-aminofluorene), of a heterocyclic amine (i.e., 2-amino-3,4-dimethylimidazo[4,5-f] and of a diamide (i.e., cyclophosphamide). The pulmonary metabolism was more oriented in the sense of detoxification, as shown by the consistent decrease of potency of direct-acting mutagens, including a metal (i.e., sodium dichromate), an acridine and nitrogen mustard derivative (i.e., 2-methoxy-6-chloro-9-[3-(2-chloromethyl)aminopropylamino]acridine or ICR 191), an epoxide (i.e., epichlorohydrin) and an N-oxide (i.e., 4-nitroquinoline-N-oxide). As assessed by means of a numerical score quantifying the variation of mutagenicity, a marked interindividual variability (up to 20-fold) was detected in the ability of lung specimens to affect the mutagenicity of test compounds. Such variability was not significantly related to the protein concentration of S-12 fractions, nor to the age of the patients under scrutiny, who during hospitalization were on normal institutional diets and did not receive any special drug treatment. The only significant difference between 20 noncancer and 60 lung cancer patients, irrespective of the histological type, was a decreased activation of cyclophosphamide in the latter group. Probably due to the high prevalence of smokers among lung cancer patients, a significantly decreased activation of cyclophosphamide was also observed in the group of smokers. Smoking habits were associated with a stimulation of detoxifying mechanisms which, in agreement with the results of a previous study with human alveolar macrophages (F. L. Petrilli et al., J. Clin. Invest., 77:1917-1924, 1986), was significant in the case of sodium dichromate. Such effect was further enhanced by considering only individuals smoking during the last 24 h before collecting lung specimens, and under these conditions it became significant also for ICR 191.(ABSTRACT TRUNCATED AT 250 WORDS)
- 1 September 1987
- Vol. 47 (17) , 4740-5
Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits.
The S-12 fractions of lung peripheral parenchyma obtained from 80 male individuals, aged 17-71 years, were assayed as blind samples for the ability either to convert promutagens into bacterial mutagens or to decrease the potency of direct-acting mutagens in the Ames reversion test. In this system, lung preparations were completely ineffective in activating an N-nitroso compound (i.e., N-nitrosomorpholine) and polycyclic aromatic hydrocarbons [i.e., 3-methylcholanthrene and benzo(a)pyrene] or their metabolites [i.e., 3-hydroxy-benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol]. They yielded a borderline and sporadic activation of a cigarette smoke condensate, and a weak but frequent activation of an aromatic amine (i.e., 2-aminofluorene), of a heterocyclic amine (i.e., 2-amino-3,4-dimethylimidazo[4,5-f] and of a diamide (i.e., cyclophosphamide). The pulmonary metabolism was more oriented in the sense of detoxification, as shown by the consistent decrease of potency of direct-acting mutagens, including a metal (i.e., sodium dichromate), an acridine and nitrogen mustard derivative (i.e., 2-methoxy-6-chloro-9-[3-(2-chloromethyl)aminopropylamino]acridine or ICR 191), an epoxide (i.e., epichlorohydrin) and an N-oxide (i.e., 4-nitroquinoline-N-oxide). As assessed by means of a numerical score quantifying the variation of mutagenicity, a marked interindividual variability (up to 20-fold) was detected in the ability of lung specimens to affect the mutagenicity of test compounds. Such variability was not significantly related to the protein concentration of S-12 fractions, nor to the age of the patients under scrutiny, who during hospitalization were on normal institutional diets and did not receive any special drug treatment. The only significant difference between 20 noncancer and 60 lung cancer patients, irrespective of the histological type, was a decreased activation of cyclophosphamide in the latter group. Probably due to the high prevalence of smokers among lung cancer patients, a significantly decreased activation of cyclophosphamide was also observed in the group of smokers. Smoking habits were associated with a stimulation of detoxifying mechanisms which, in agreement with the results of a previous study with human alveolar macrophages (F. L. Petrilli et al., J. Clin. Invest., 77:1917-1924, 1986), was significant in the case of sodium dichromate. Such effect was further enhanced by considering only individuals smoking during the last 24 h before collecting lung specimens, and under these conditions it became significant also for ICR 191.(ABSTRACT TRUNCATED AT 250 WORDS)
- 1 November 1985
- Vol. 5 (4) , 252-5
Radiographic assessment of perfusion impairment in pulmonary embolism.
To assess whether radiographic features of descending pulmonary artery reflect the severity of the vascular obstruction we reviewed chest radiographs and perfusion lung scans in 115 patients affected by pulmonary embolism. Patients were classified according to the radiographic appearance of the descending pulmonary artery: normal, enlarged, and markedly enlarged with "sausage" shape. At acute embolization, patients with "sausage" appearance of the artery had the most serious vascular obstruction (56% on the average), in respect to patients with simply enlarged arteries (39% obstruction on the average, p less than 0.001) and patients with normal arteries who had the smallest obstruction (26% on the average, p less than 0.001). At recovery, patients showed a parallel decrease of descending pulmonary artery width and vascular obstruction.
- 1 November 1985
- Vol. 5 (4) , 252-5
Radiographic assessment of perfusion impairment in pulmonary embolism.
To assess whether radiographic features of descending pulmonary artery reflect the severity of the vascular obstruction we reviewed chest radiographs and perfusion lung scans in 115 patients affected by pulmonary embolism. Patients were classified according to the radiographic appearance of the descending pulmonary artery: normal, enlarged, and markedly enlarged with "sausage" shape. At acute embolization, patients with "sausage" appearance of the artery had the most serious vascular obstruction (56% on the average), in respect to patients with simply enlarged arteries (39% obstruction on the average, p less than 0.001) and patients with normal arteries who had the smallest obstruction (26% on the average, p less than 0.001). At recovery, patients showed a parallel decrease of descending pulmonary artery width and vascular obstruction.
- 1 January 1985
- Vol. 71, 26-30
[Clinical significance of the enlargement of the descending pulmonary artery in pulmonary embolism].
The authors reviewed chest radiographs of 158 patients with clinical suspicion of pulmonary embolism, subsequently confirmed in 73 and excluded in 85. Right descending pulmonary artery, measured at 4 different levels, was significantly enlarged at acute embolization in respect to either the diameter showed at recovery and the upper normal limit reported in literature. Moreover, the artery was significantly wider in embolic than in non embolic patients. In addition, the shape of this artery was modified in embolism, since the prevailing enlargement of its upper sections caused the artery to take a truncated cone appearance. "Sausage" appearance of the artery, never found in non embolic patients, was specific for embolism. The radiographic width of the descending pulmonary artery enabled also to identify patients most seriously ill, since it showed a positive linear correlation with the degree of perfusion impairment.
- 1 January 1985
- Vol. 71, 26-30
[Clinical significance of the enlargement of the descending pulmonary artery in pulmonary embolism].
The authors reviewed chest radiographs of 158 patients with clinical suspicion of pulmonary embolism, subsequently confirmed in 73 and excluded in 85. Right descending pulmonary artery, measured at 4 different levels, was significantly enlarged at acute embolization in respect to either the diameter showed at recovery and the upper normal limit reported in literature. Moreover, the artery was significantly wider in embolic than in non embolic patients. In addition, the shape of this artery was modified in embolism, since the prevailing enlargement of its upper sections caused the artery to take a truncated cone appearance. "Sausage" appearance of the artery, never found in non embolic patients, was specific for embolism. The radiographic width of the descending pulmonary artery enabled also to identify patients most seriously ill, since it showed a positive linear correlation with the degree of perfusion impairment.